Research funder · United States
Melanoma Research Alliance
Nonprofit organization in Washington D.C., United States
- Grants since 2016
- 400
- Awarded, last 5 years (where amounts are published)
- 72.1M
- Funded works, last 5 years
- 1 190
- Funded works, all time
- 2 826
Grants
2024–2026 · award
Targeting YAP1-TEAD in acral melanoma
Andrew Aplin · Thomas Jefferson University
2024–2026 · award
Spatiotemporal profiling of the aged microenvironment in tumor dormancy and recurrent disease
Ashani Weeraratna
2024–2026 · award
Development of a novel CD73 protein degrader for melanoma immunotherapy
Bin Zhang · Northwestern University
2024–2027 · award
Tumor-Reactive T Cells To Treat Melanoma Leptomeningeal Disease
Yolanda Pina · Moffitt Cancer Center
2024–2026 · award
Melanoma selective CAR T cells
Adam Hurlstone · University of Manchester
2024–2025 · award
Aggregation & Harmonization of MultiModal International Acral Melanoma Data
Sophia Shalhout · Massachusetts Eye and Ear Infirmary
2024–2026 · award
Next-Generation Melanoma Transcriptional inhibitors
Liron Bar-Peled · Massachusetts General Hospital
2024–2027 · award
A molecular glue to degrade tumor-surface PD-L1 and improve therapies
Roger Lo · The Regents Of The University Of California, Los Angeles
2024–2026 · award
Harnessing pDC-derived exosomes for enhanced melanoma immunotherapy
Aimin Jiang · Henry Ford Health
2024–2027 · award
Overcoming resistance to immune checkpoint blockade therapy with PSGL-1
Jennifer Hope · Drexel University
2024–2027 · award
Elucidating metabolic modulators to enhance Treg-TME melanoma immunotherapy
Ariella Glasner · Technion – Israel Institute of Technology
2024–2027 · award
Targeting suppressive macrophages to overcome resistance to immunotherapy
Brian Miller · University of North Carolina at Chapel Hill
2024–2026 · award
Immunotherapeutic cytokine/antibody fusion protein to treat acral melanoma
Jamie Spangler · Johns Hopkins University
2024–2027 · award
Harnessing Tissue-Resident Lymphocytes as a Melanoma Biomarker
Joshua Moreau · Oregon Health & Science University
2024–2026 · award
The role of the microbiome and treatment response in rare melanoma subtypes
Florentia Dimitriou · The University of Texas MD Anderson Cancer Center
2024–2027 · award
Molecular alterations and therapeutics for high-risk uveal melanoma
Anne Bowcock · Icahn School of Medicine at Mount Sinai
2024–2027 · award
Enabling AI for Early Detection of Melanoma in Smartphone Images
Allan Halpern · Memorial Sloan Kettering Cancer Center
2024–2026 · award
A hyperactive heterodimeric histone methyl transferase in melanoma
Bassem Al-Sady · Regent University
2024–2026 · award
Point-of-Care High-frequency Quantitative Ultrasound Assessment of Melanoma
Jonathan Mamou · Cornell University
2024–2027 · award
Targeting CTLA-4 to optimize the management of melanoma brain metastasis
Ryan Sullivan · Massachusetts General Hospital
2024–2026 · award
"Piloting" Cellular Therapy in Uveal Melanoma with Lifileucel
Alexander Shoushtari · Memorial Sloan Kettering Cancer Center
2024–2027 · award
Harnessing the tumor immune microenvironment of brain metastases
Lisa Sudmeier · Emory University
2024–2027 · award
Organoid modeling of melanoma checkpoint inhibitor response and resistance
Calvin Kuo · The Board Of Trustees Of The Leland Stanford Junior University
2024–2027 · award
The role of aging in immune-regulated reactivation from metastatic melanoma
Mitchell Fane · Fox Chase Cancer Center
2024–2027 · award
Spatial Vascular Patterns and Immune Exclusion Mechanisms in Melanoma
Minah Kim · Columbia University Irving Medical Center
2024–2026 · award
Developing S6K2-selective degraders: A novel approach for acral melanoma
Jessie Villanueva · The Wistar Institute
2024–2026 · award
Identification of the next generation of microbiome therapeutics in combination with immune checkpoint blockade to improve outcomes for patients with melanoma
Arielle Elkrief · Université de Montréal
2024–2027 · award
Optimizing the immune mediated-destruction of NRAS mutant melanoma
Keiran Smalley · Moffitt Cancer Center
2024–2027 · award
Delineating T-cell migratory patterns in immunotherapy-treated melanoma
Katie Campbell · The Regents Of The University Of California, Los Angeles
2024–2026 · award
Targeting oncogenic TERT promoter mutations with small molecules
Carl De Boer · University of British Columbia
2024–2026 · award
Deep learning pathology image analysis of neoadjuvant treated melanoma
Nigel Maher · Melanoma Institute Australia
2024–2027 · award
Studying Acral & Mucosal Melanoma's Cellular Networks & Immune resistance
Matthew Krummel · Regent University
2024–2026 · award
Recombinant Modified Vaccinia Virus Ankara for Acral Melanoma Immunotherapy
Liang Deng · Memorial Sloan Kettering Cancer Center
2024–2027 · award
Targeting BRAF mutated melanoma with CD4+ T cells
Joshua Veatch · Fred Hutch Cancer Center
2024–2027 · award
Targeting cancer-associated aberrant RNA to treat metastatic melanoma
Megan Insco · Dana-Farber Cancer Institute
2024–2027 · award
Characterize antigen-presenting astrocytes to inhibit melanoma brain metast
Neta Erez · Tel Aviv University
2024–2027 · award
Dissecting neural-like cell states in melanoma brain metastasis
Benjamin Izar · Columbia University Irving Medical Center
2024–2027 · award
Interrogating the role of CD27-CD8+ T cells in immunotherapy responses
Frank Hodi · Dana-Farber Cancer Institute
2024–2026 · award
A molecular driver of exceptional response to immune checkpoint treatments
Hans Widlund · Brigham and Women's Hospital
2023–2026 · award
Harnessing the immunomodulatory effects of NK cells in melanoma
Kevin Barry · Fred Hutch Cancer Center